全程化药学服务对冠心病患者用药安全和临床相关指标的影响  

The Impact of Comprehensive Pharmaceutical Services on Medication Safety and Clinical Related Indicators in Patients with Coronary Heart Disease

作　　者：刘丽霞 LIU Lixia(Department of Pharmacy,Jiyang District Xinshi Town Health Center,Ji'nan 251400,China)

机构地区：[1]济南市济阳区新市镇卫生院药剂科,济南251400

出　　处：《中国医药指南》2024年第23期97-99,共3页Guide of China Medicine

摘　　要：目的观察全程化药学服务对冠心病患者用药安全和临床相关指标的影响。方法数据选取于2022年6月至2023年6月期间本院收治的冠心病患者121例纳入研究,根据随机数字表法将其分成对照组60例与观察组61例,其中对照组实施常规干预服务,观察组实施全程化药学干预服务。比较两组药物不良反应发生率、干预前后临床相关指标的影响。结果观察组药物不良反应发生率比对照组更低(P<0.05)。两组干预后各项血脂水平均比同组干预前更低,且观察组干预后各项血脂水平均比对照组更低(P<0.05)。两组干预后各项心功能水平均比同组干预前更优,且观察组干预后各项心功能水平均比对照组更优(P<0.05)。两组干预后QOL3量表各项评分均比同组干预前更高,且观察组干预后QOL3量表各项评分均比对照组更高(P<0.05)。结论全程化药学服务可改善冠心病患者临床相关指标,降低药物不良反应发生率,有助于缩短患者康复进程。Objective To observe the impact of comprehensive pharmaceutical services on medication safety and clinical related indicators in patients with coronary heart disease.Methods A total of 121 patients with coronary heart disease admitted to our hospital between June 2022 and June 2023 were selected for the study.They were divided into a control group of 60 cases and an observation group of 61 cases using the random number table method.The control group received routine intervention services,while the observation group received full process pharmaceutical intervention services.Compare the incidence of adverse drug reactions and the impact of clinical indicators before and after intervention between two groups.Results The incidence of adverse drug reactions in the observation group was lower than that in the control group(P<0.05).After intervention,the levels of various blood lipids in both groups were lower than before intervention,and the observation group had lower levels of various blood lipids than the control group(P<0.05).After intervention,the levels of various cardiac functions in both groups were better than before intervention,and the observation group had better levels of various cardiac functions than the control group after intervention(P<0.05).After intervention,the scores of the QOL3 scale in both groups were higher than before intervention,and the observation group had higher scores than the control group(P<0.05).Conclusions Full process pharmaceutical services can improve clinical indicators of coronary heart disease patients,reduce the incidence of adverse drug reactions,and help shorten the recovery process of patients.

关 键 词：全程化药学服务 冠心病 用药安全 血脂水平 心功能 

分 类 号：R541.4[医药卫生—心血管疾病] R969.3[医药卫生—内科学]